Ceforanide: In Vitro and Clinical Evaluation

Ceforanide, a new cephalosporin antibiotic with a long half-life (3 h), can be administered twice daily. We evaluated its antimicrobial activity, pharmacology, and clinical efficacy. Twenty-seven patients with infections due to susceptible organisms received ceforanide, 0.5, 1, or 2 g, intramuscular...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Antimicrob Agents Chemother
Asıl Yazarlar:	Burch, Keith H., Pohlod, Donald, Saravolatz, Louis D., Madhavan, Tom, Kiani, Daria, Quinn, Edward L., Del Busto, Ramon, Cardenas, Julio, Fisher, Evelyn J.
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1979
Konular:	Pharmacology and Therapeutics
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC352865/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/507795/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.16.3.386
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Ceforanide: In Vitro and Clinical Evaluation

Benzer Materyaller